Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007065 |
---|---|
Receipt number | R000008071 |
Scientific Title | Phase 2 study of bevacizumab and irinotecan as second-line therapy in patients with advanced colorectal cancer previously treated with oxaliplatin and bavacizumab |
Date of disclosure of the study information | 2012/01/16 |
Last modified on | 2012/02/10 16:51:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/01/13 15:49:24 | ||
2 | Update | 2012/02/10 16:51:57 | Recruitment status |